Edition:
United States

Insider Trading: aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Global Select Market

3.30USD
28 Apr 2017
Change (% chg)

$-0.20 (-5.71%)
Prev Close
$3.50
Open
$3.50
Day's High
$3.50
Day's Low
$3.25
Volume
6,292
Avg. Vol
27,383
52-wk High
$4.45
52-wk Low
$2.12

LUCIER GREGORY T

Institutional Holders

% Shares Owned: 80.34%
# of Holders: 60
Total Shares Held: 19,079,467
3 Mo. Net Change: 962,959
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 2
# Net Buyers: 0

Officers & Directors

Name Age Since Current Position

John Mendlein

56 2011 Chief Executive Officer and Executive Chairman, Board of Directors

John Clarke

63 2005 Non-Executive Independent Chairman of the Board

John Blake

39 2016 Principal Financial Officer, Chief Accounting Officer

David King

2016 Senior Vice President - Research

Melissa Ashlock

57 2011 Vice President - External Scientific Alliances and Human Genetics

Holly Chrzanowski

49 2013 Vice President - Enterprise Talent and Organization

Andrew Cubitt

52 2011 Vice President - Product Protection

John McKew

51 2014 Vice President - Research

Fred Ramsdell

54 2014 Vice President - Immunology

Sanuj Ravindran

2016 Chief Business Officer

Sanjay Shukla

2016 Chief Medical Officer

Timothy Coughlin

49 2017 Director

Jeffrey Hatfield

2017 Director

Srinivas Akkaraju

48 2015 Non-Executive Independent Director

James Blair

76 2010 Non-Executive Independent Director

Kathryn Falberg

55 2014 Non-Executive Independent Director

Mark Goldberg

61 2015 Non-Executive Independent Director

Amir Nashat

38 2006 Non-Executive Independent Director

Paul Schimmel

76 2005 Non-Executive Independent Director